- PROCTO3 REPORT AT Gastroenterology, Hepatobiliary, and Biliary Department - FV HOSPITAL (17/01/2024 )
- GLIGCA REPORT AT SPINE DEPARTMENT B – HCMC ORTHOPEDIC TRAUMA HOSPITAL (17/01/2024 )
- REPORT TAMDEFLO, CAPSER, VOCFOR, DEGODAS CAN THO CENTRAL GERD (17/01/2024 )
- REPORT TAMDEFLO ORTHOPEDIC TRAUMA DEPARTMENT (17/01/2024 )
- CAPSER REPORT FOR MUSCULOSCOPIC AND JOINT DEPARTMENT OF CHO RAY HOSPITAL (17/01/2024 )
- TAMDEFLO MINH DUC HOSPITALOn October 21, 2023, Medbolide Joint Stock Company had a report to introduce the product TAMDEFLO (deflazacort 6mg) at the hall of Minh Duc Hospital, Ben Tre. The report took place with the participation of more than 30 Doc (17/01/2024 )
- Report TAMDEFLO Thong Nhat Hospital (17/01/2024 )
- Report TAMDEFLO MEDIC BINH DUONG (17/01/2024 )
- GLIGCA REPORT AT THE PHARMACY DEPARTMENT - FV HOSPITAL (11/01/2024 )
- Report CAPSER, DEGODAS – JOINT DEPARTMENT OF ORTHOPEDIC TRAUMA HOSPITAL (16/10/2023 )
CAPSER – ENDOCRINE DEPARTMENT, CHO RAY HOSPITAL
Tuesday, September 12, 2023, at the endocrine department of Cho Ray Hospital. CPDP Medbolide Company had a report introducing the nerve pain reliever product CAPSER (Capsaicin 0.075%) to treat shingles, diabetic nerve pain and musculoskeletal pain. The report took place with the attendance of more than 30 Doctors and medical staff.
The company representative presented recommendations and clinical research proving the effectiveness of the drug CAPSER containing the active ingredient Capsaicin at a concentration of 0.075%, an active ingredient with a new mechanism. Provides good pain relief and does not cause systemic side effects.
Medbolide Company sends its thanks and hopes to continue accompanying the Hospital in bringing solutions to improve the quality of life for patients.
Readers comments